Sunday 15/March/2026 – 08:08 AM
The Egyptian Medicines Authority warned of the possibility of circulating packages of unknown origin of a topical antiseptic preparation called “GERMADINE ANTISEPTIC SOLUTION,” known as Germadine Antiseptic Solution, after receiving a notification from Panax Pharma stating the presence of packages of unknown origin that carry unapproved operating data.
Warning against circulating unidentified packages of Germadin disinfectant
The Authority explained that the aforementioned preparation is used as a topical skin disinfectant, as it helps in sterilizing minor wounds and scratches, and reducing the growth of bacteria and microbes on the skin. It is usually used in first aid and cleaning wound sites before or after simple medical procedures.
According to the Authority’s statement, the packages under warning bear the name of the manufacturer written on the package, Panax Pharma for BioGuard for Suppliers, with the batch number 19377, indicating that this batch is of unknown origin and is not officially traded in the Egyptian drug market.
The Authority confirmed that the warning comes within the framework of periodic follow-up procedures and monitoring of pharmaceutical preparations circulating in the markets, stressing the continuation of corrective measures and continuous follow-up of pharmaceutical items, in addition to intensifying awareness campaigns for citizens regarding the dangers of circulating medicines and preparations of unknown origin.
The Medicines Authority appealed to citizens to purchase pharmaceutical preparations only from licensed pharmacies, to ensure obtaining safe products that comply with quality requirements, stressing that in the event of suspicion of any pharmaceutical preparation, the Authority can be contacted via the hotline 15301 or through the official website for reporting or inquiries.
The Authority stressed that the preparations mentioned in the warning are of unknown origin and are not authorized for circulation in the Egyptian pharmaceutical market, calling on citizens to avoid purchasing medicines or pharmaceutical preparations online or from unapproved sources, in order to preserve public health and ensure the safety of the preparations in circulation.
